Traditional Chinese medicine preparation for treating tachycardia

Treating tachycardia with a specific ratio of traditional Chinese medicine preparations targets the pathogenesis of heart yin deficiency, qi deficiency, and phlegm stasis and blood stasis, improves tachycardia symptoms, solves the problems of insufficient Western medicine treatment and lack of treatment options in traditional Chinese medicine, and achieves significant clinical efficacy and safety.

CN118873604AActive Publication Date: 2024-11-01GUANGANMEN HOSPITAL CHINA ACAD OF CHINESE MEDICAL SCI
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411132853.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-01
Estimated Expiration
2044-08-19

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine preparation for treating tachycardia. The traditional Chinese medicine preparation is prepared from the following raw material medicines: 10-20 g of cassia twig, 10-20 g of bighead atractylodes rhizome, 15-25 g of codonopsis pilosula, 15-25 g of radix rehmanniae preparata, 25-35 g of crude dragon bone, 25-35 g of raw oyster shell, 10-20 g of radix sophorae flavescentis, 10-20 g of schisandra chinensis, 15-25 g of rhizoma nardostachyos, 10-20 g of radix ophiopogonis and 10-20 g of turtle shell. During treatment, the traditional Chinese medicine preparation for treating tachycardia is orally taken, one dose of the traditional Chinese medicine preparation is taken twice a day, the traditional Chinese medicine preparation is taken half an hour after breakfast and supper, and a course of treatment lasts for four weeks continuously. The traditional Chinese medicine preparation for treating tachycardia can obviously improve the symptoms such as palpitation and shortness of breath, dysphoria in the heart, hectic fever and night sweat, insomnia and dreaminess, anxiety and the like, is remarkable in curative effect, good in safety, low in price, simple in medicine and high in clinical popularization value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a traditional Chinese medicine preparation for treating tachycardia, belonging to the technical field of traditional Chinese medicine preparations. Background Art

[0002] The clinical symptoms of tachycardia are obvious, and the patient feels strong physical discomfort. Common pathological tachycardias in clinical practice are divided into sinus tachycardia, supraventricular tachycardia, rapid atrial fibrillation, ventricular tachycardia, etc. Whether paroxysmal or persistent, they are prone to cause serious complications such as cardiomyopathy and heart failure. If combined with hemodynamic instability, tachycardia has a very high mortality rate and is an important cause of sudden cardiac death. In clinical practice, some patients have obvious discomfort, but no clear arrhythmia is captured. Most of them are middle-aged and elderly women, which is called functional tachycardia. Supraventricular tachycardia is one of the most common arrhythmias. Supraventricular tachycardia refers to a group of rapid arrhythmias in which the site of ectopic excitation or the reentrant circuit is above the His bifurcation. Clinically, supraventricular tachycardia includes atrial tachycardia (AT), atrial flutter (AF), sinoatrial reentrant tachycardia, atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT). Atrial tachycardia and atrial flutter are more common in patients with organic cardiopulmonary diseases, such as chronic obstructive pulmonary disease and valvular heart disease. They can occur after cardiac and thoracic surgery and are also seen in patients without clear organic heart disease. AVNRT and AVRT are more common in patients without organic heart disease. The onset and termination of tachycardia are often sudden. In young patients without organic heart disease, the frequency is less than 200 beats / minute and the duration is short. Most of them only have sudden palpitations, sometimes accompanied by fear, uneasiness and polyuria. In patients with organic heart disease, the frequency is greater than 200 beats / minute and the duration is long, which can cause insufficient blood supply to the heart, brain and other organs, leading to a drop in blood pressure, dizziness, blackouts, angina pectoris, heart failure, etc.

[0003] In Western medicine, antiarrhythmic drugs, radiofrequency ablation, and implantable cardioverter defibrillator (ICD) implantation are developing rapidly. However, there are still patients with functional lesions, patients with poor drug effects, patients with difficulty in complete radiofrequency ablation, and patients with frequent ICD discharges who feel severe discomfort, and suffer huge blows to their physical, psychological, and financial health.

[0004] There is no exact record of this disease in the books of traditional Chinese medicine, but because the onset characteristics of diseases such as "palpitations" and "palpitations" are similar to this disease, it can be used as a basis. Therefore, further research is needed to seek an exact Chinese medicine compound preparation to meet domestic and foreign needs. Summary of the invention

[0005] In view of the above-mentioned prior art, the present invention provides a traditional Chinese medicine preparation for treating tachycardia.

[0006] The present invention is achieved through the following technical solutions: A traditional Chinese medicine preparation for treating tachycardia is prepared from the following raw materials: 10-20 g of cinnamon twig, 10-20 g of atractylodes macrocephala, 15-25 g of codonopsis pilosula, 15-25 g of rehmannia glutinosa, 25-35 g of raw dragon bone, 25-35 g of raw oyster, 10-20 g of sophora flavescens, 10-20 g of schisandra chinensis, 15-25 g of nardus galangus, 10-20 g of ophiopogon japonicus, and 10-20 g of turtle shell.

[0007] Preferably, it is made from the following raw materials: 15 g of cinnamon twig, 15 g of atractylodes macrocephala, 20 g of codonopsis pilosula, 20 g of rehmannia glutinosa, 30 g of raw dragon bone, 30 g of raw oyster, 15 g of sophora flavescens, 15 g of schisandra chinensis, 20 g of nardus galangus, 15 g of ophiopogon japonicus, and 15 g of turtle shell.

[0008] The preparation method of the Chinese medicine preparation for treating tachycardia comprises the following steps: (1) Mix raw dragon bones, raw oysters and turtle shells, soak them in water for 20 to 40 minutes and set aside; mix cinnamon twigs, white atractylodes, codonopsis, rehmannia, sophora flavescens, schisandra chinensis, nard and ophiopogon japonicus, soak them in water for 20 to 40 minutes and set aside; (2) Boil raw dragon bones, raw oysters and turtle shells for 20 to 30 minutes (raw dragon bones, raw oysters and turtle shells are hard medicinal materials such as minerals and shells, so they should be boiled first); (3) Add cinnamon twig, white atractylodes, codonopsis pilosula, rehmannia root, sophora flavescens, schisandra chinensis, nardostachys grandiflora and ophiopogon japonicus, and boil for 30 to 50 minutes. Pour out the decoction. This is the first decoction. Add water to the residue and boil for another 30 to 50 minutes. Pour out the decoction. This is the second decoction. Mix the two decoctions together.

[0009] Furthermore, in the step (1), the soaking time is 30 minutes.

[0010] Furthermore, in the step (2), the decocting time is 25 minutes.

[0011] Furthermore, in step (3), the decocting time is 40 minutes.

[0012] The Chinese medicine preparation for treating tachycardia of the present invention has the following treatment idea: the occurrence of the disease is mainly due to heart yin deficiency. "Danxi Heart Method" states: "The heart is the master of the human body, and the heart nourishes the blood. Once the heart blood is deficient, the spirit and energy are not maintained, which is the origin of palpitations." Heart yin includes the body fluid, blood, and yin essence of the heart, and heart blood is also a part of heart yin. The function of the heart to control blood vessels and consciousness must rely on the nourishment of heart yin and the filling of heart blood. The main causes include: first, excessive thinking and fatigue, emotional damage, and secret consumption of heart yin, as stated in "Luo Shi Hui Yue Yi Jing·On Palpitations": "I cannot concentrate on everything, and thinking is even worse. This is caused by excessive thinking that damages the heart blood"; second, Yin deficiency in the body, or long-term illness and physical decline, malnutrition of the body, or heat disease damaging Yin, leakage of Yin fluid, or improper treatment or misdiagnosis, excessive intake of hot drugs, which damage Yin fluid and lead to heart yin deficiency; third, old age and physical decline, "Su Wen·Yin Yang Ying Xiang Da Lun" says: "At the age of forty, the Yin Qi is halved, and the daily life is declining", indicating that after middle age, the body's Yin Qi begins to be deficient, the functions of the internal organs are weakened, and the heart yin is deficient; fourth, liver and kidney deficiency, which damages the heart yin over time. When the heart yin is damaged, the heart loses nourishment; at the same time, insufficient yin fluid can lead to qi deficiency, so "Lingshu Benshen Pian" says: "If the yin is deficient, there is no qi"; yin and yang are mutually dependent, and yin deficiency can damage yang qi over a long period of time, which can lead to yang deficiency; when yin deficiency is long-term, yin cannot control yang, yang qi is hyperactive, virtual fire is generated internally, and liquid is refined into phlegm, and phlegm and fluid accumulate in the heart meridian; phlegm turbidity is generated internally, blocking the meridians, blood cannot flow, and blood stasis occurs, and blood stasis blocks the flow; phlegm turbidity and blood stasis can block the qi mechanism, leading to qi stagnation; qi stagnation can promote the formation of blood stasis and phlegm turbidity. The three combine to make the weak more weak, and the deficiency leads to excess, aggravating the condition. On the basis of the etiology and pathogenesis, the invention develops a prescription for nourishing yin, calming the mind and calming palpitations, wherein the Radix Rehmanniae Preparata nourishes yin and blood; Radix Ophiopogonis nourishes yin and clears the heart; Carapace of Turtle nourishes yin and subdues yang, the three medicines are used together to nourish the heart yin and nourish the heart blood, and cinnamon twig is used together to warm and nourish the heart yang to help the heart yin to be transformed, and cinnamon twig is used together with Schisandra chinensis to subdue yang below to control the hyperactive yang, so that the dragon returns to the sea, and its qi is restrained by itself; Codonopsis pilosula is added to replenish qi and nourish blood, and qi, blood, yin and yang are all replenished. Raw oyster and raw dragon bone are used together to calm the mind, and at the same time, they can play the role of astringing sweat and prevent the heart yin from being damaged. Schisandra chinensis can be astringent, invigorate qi and produce body fluid, nourish the kidney and calm the mind, and can be used for spontaneous sweating, night sweating, thirst caused by body fluid damage, internal heat and thirst, palpitations and insomnia. At the same time, Sophora flavescens is used to clear heat, and Atractylodes macrocephala and Ganoderma lucidum are added to replenish qi and strengthen the spleen to resolve phlegm turbidity, and at the same time, drug absorption can be promoted.

[0013] The drug compatibility of the present invention is unique, not only focusing on the synergistic effect between drugs, but also avoiding the antagonistic effect between drugs. For example, cinnamon twig and licorice can enhance the effect of warming and nourishing the heart yang; raw dragon bone and raw oyster can enhance the effect of calming the nerves; bitter ginseng and ophiopogon can be matched to clear away heat and nourish yin without hurting the body. This unique drug compatibility method helps to improve the overall efficacy. The reason why the present invention chooses raw oysters is that raw oysters have unique medicinal value and efficacy in traditional Chinese medicine theory. It can not only calm the nerves, suppress yang and replenish yin, but also is particularly suitable for patients with tachycardia accompanied by symptoms such as palpitations and insomnia, and its rich minerals and trace elements also have a certain regulating effect on cardiac function. More importantly, raw oysters have better compatibility with other drugs in the present invention. For example, when matched with raw dragon bone, it can enhance the effect of calming the nerves, and has a significant effect on relieving the nervousness and anxiety of patients with tachycardia; when matched with bitter ginseng, it can clear away heat and dampness, regulate the damp and hot state in the body, thereby indirectly improving cardiac function. Therefore, considering the unique efficacy of raw oysters and their compatibility effects in the present invention, the present invention selects raw oysters as one of the key raw materials.

[0014] The Chinese medicine preparation for treating tachycardia of the present invention is taken orally during treatment (the drug exerts its therapeutic effect through absorption through the gastrointestinal mucosa), one dose per day (the dosage of each raw material drug recorded above is the amount of one dose), taken in two doses, half an hour after breakfast and dinner, and taken continuously for 4 weeks as a course of treatment.

[0015] The Chinese medicine preparation for treating tachycardia of the present invention has significantly better improvement in symptoms such as palpitation and shortness of breath, fever in the five parts of the heart, hot flashes and night sweats, insomnia and dreaminess, anxiety and restlessness than the control group (oral metoprolol), with statistical significance (P < 0.05). The improvement in TCM syndrome score is better than that of the control group, with statistical significance (P < 0.05). The Chinese medicine preparation for treating tachycardia of the present invention has significant efficacy, good safety, low price and simple medicine, and has high clinical promotion value.

[0016] Various terms and phrases used herein have the general meanings that are well known to those skilled in the art. DETAILED DESCRIPTION

[0017] The present invention will be further described below in conjunction with the embodiments. However, the scope of the present invention is not limited to the following embodiments. It will be appreciated by those skilled in the art that various changes and modifications may be made to the present invention without departing from the spirit and scope of the present invention.

[0018] The instruments, reagents, and materials involved in the following examples, unless otherwise specified, are all conventional instruments, reagents, and materials available in the prior art and can be obtained through regular commercial channels. The experimental methods, detection methods, etc. involved in the following examples, unless otherwise specified, are all conventional experimental methods and detection methods available in the prior art.

[0019] Example 1 Preparation of Chinese medicine preparation for treating tachycardia The formula is: 15 g of cinnamon twig, 15 g of atractylodes macrocephala, 20 g of codonopsis pilosula, 20 g of cooked rehmannia, 30 g of raw dragon bone, 30 g of raw oyster, 15 g of sophora flavescens, 15 g of schisandra chinensis, 20 g of nardus galangus, 15 g of ophiopogon japonicus, and 15 g of turtle shell. Each raw material drug is selected from the corresponding Chinese herbal medicine pieces.

[0020] The preparation method is as follows: (1) Mix raw dragon bone, raw oyster and turtle shell, soak in water for 30 minutes and set aside; mix cinnamon twig, white atractylodes, codonopsis, prepared rehmannia, sophora flavescens, schisandra chinensis, nard and ophiopogon japonicus, soak in water for 30 minutes and set aside; (2) Boil raw dragon bones, raw oysters and turtle shells for 25 minutes; (3) Add cinnamon twig, white atractylodes, codonopsis pilosula, rehmannia root, sophora flavescens, schisandra chinensis, nardostachys grandiflora and ophiopogon japonicus, boil for 40 minutes, and pour out the decoction. This is the first decoction. Add water to the residue and boil for another 40 minutes. Pour out the decoction. This is the second decoction. Mix the two decoctions together.

[0021] Clinical research data Preliminary research by the research group to which the inventor of the present invention belongs has shown that the prescription can significantly improve the patient's tachycardia-related symptoms, significantly improve the patient's discomfort symptoms and TCM syndrome scores, and has good safety, which fully demonstrates the advantages of TCM in treating tachycardia. At the same time, the inventor of the preparation method has summarized many years of clinical experience, which provides safe and effective guarantees for its clinical promotion and application.

[0022] 1. Clinical data 1.1 Diagnostic criteria 1.1.1 Western medicine diagnostic criteria The Western medicine diagnostic standards for this study, "Chinese Expert Consensus on the Diagnosis, Treatment and Treatment of Supraventricular Tachycardia (2021)" and "Guidelines for the Diagnosis and Treatment of Supraventricular Tachycardia at the Primary Level (2019)", are formulated as follows: (1) Heart rate 150-250 beats / min, regular rhythm.

[0023] (2) The QRS wave morphology and duration are normal, but when intraventricular aberrant conduction or pre-existing bundle branch block occurs, the QRS wave morphology is abnormal.

[0024] (3) Retrograde P′ waves can be seen in some patients, often located at the end of the QRS wave (pseudo-s waves in leads II, III, and aVF, pseudo-r′ waves in leads aVR and V1) or in the ST segment or ascending limb of the T wave. The relationship between the QRS wave and the P′ wave is fixed.

[0025] (4) The onset is sudden, often triggered by an atrial premature beat, which significantly prolongs the PR interval and then causes a supraventricular attack.

[0026] 1.1.2 TCM diagnosis and quantitative standards TCM diagnosis is in line with the diagnosis of central yin deficiency type in all patients according to the "Standards for Diagnosis and Efficacy of TCM Diseases and Syndromes". The main symptoms are abnormal heartbeats, or excessive heartbeats, or sudden heartbeats and stops. They are paroxysmal or persistent, with nervous expressions and uneasiness. Secondary symptoms are palpitations and restlessness, especially worry and fatigue, irritability in the heart, less sleep and more dreams, dizziness, tinnitus, dry mouth, and hot cheeks. The tongue is red, the coating is thin and yellow, and the pulse is thin and stringy. There are 2 main symptoms, and 3 of the secondary symptoms can be diagnosed.

[0027] 1.2 Inclusion criteria (1) Meet the above diagnostic criteria; (2) Aged 18 to 60 years old; (3) Have not used hormone or psychiatric drugs, or have stopped using them several months ago, and can promise not to take other related drugs voluntarily during treatment; (4) Those without drug dependence; (5) Those without serious suicidal tendencies; (6) Those who can be followed up; (7) Volunteers who participate in this study.

[0028] 1.3 Exclusion criteria (1) Those who are prone to allergies or are allergic to this drug; (2) Suffering from cardiovascular, cerebrovascular or other organic diseases; (3) Patients with other neurological, psychiatric and endocrine diseases; (4) Patients with drug or alcohol dependence in the past 3 months or who have participated in other research projects or taken other sedatives.

[0029] 1.4 Suspension and Exit Criteria (1) Those who did not use the drugs as required during the experiment; (2) Patients experience severe adverse reactions or changes in their condition; (3) Those who voluntarily requested to withdraw from the experiment; (4) Those who take related drugs on their own during treatment. Those who are prone to allergies or are allergic to this drug.

[0030] 1.4 Elimination criteria (1) Those who are found to not meet the inclusion criteria or meet the exclusion criteria after inclusion; (2) Those who were found to have poor compliance and could not strictly follow the treatment plan after inclusion; (3) Patients who use prohibited drugs at will during treatment after inclusion.

[0031] 1.5 Shedding Standard (1) Poor compliance or combined use of drugs outside the prescribed range affects the efficacy and safety judgment; (2) Those who have allergic reactions or serious adverse events and are not suitable to continue treatment; (3) Those who cannot continue the clinical trial due to various reasons, or who withdraw from or terminate the trial.

[0032] 1.6 General Information The included patients were patients who visited the outpatient department from January 2019 to January 2022, aged 18 to 60 years old, diagnosed with tachycardia, totaling 60 cases. They were randomly divided into the oral Chinese medicine preparation Yangyin Anshen Dingji Fang group and the Western medicine group, 30 cases in each group. There was no significant difference in age between the groups, and there was baseline consistency (P>0.05).

[0033] 2. Methods 2.1 Treatment methods Treatment group: Yangyin Anshen Dingji prescription (i.e. the Chinese medicine preparation of the present invention, prepared in Example 1), 1 dose per day, taken half an hour after breakfast and dinner for 4 consecutive weeks.

[0034] Control group: Oral administration of metoprolol tartrate (AstraZeneca Pharmaceuticals Co., Ltd., National Medicine Standard No. H32025391, specification 50 mg, 20 tablets), once a day, 1 tablet each time, before breakfast, for 4 consecutive weeks.

[0035] 2.2 Observation indicators 2.2.1 General data observation Observe and record the patient's age, disease progression, disease changes during treatment, and any adverse drug reactions during treatment.

[0036] 2.2.2 Evaluation of treatment effect (record once before and after treatment) Cardioversion success rate and time, and TCM syndrome score.

[0037] 3. Safety evaluation During treatment, patients should monitor their blood pressure, heart rate and other vital signs. Blood, urine, stool routine tests, and liver and kidney function tests should be performed in a timely manner before and after treatment.

[0038] 2.3 Criteria for determining efficacy 2.3.1 Western medicine efficacy standards Dynamic electrocardiogram changes: Markedly effective: the average heart rate dropped to 60-100 beats / min; Effective: the average heart rate decreased by 20% or more compared with before medication; Ineffective: the average heart rate did not change; Aggravated: the average heart rate increased by 20% or more compared with before medication.

[0039] 2.3.2 TCM efficacy standards The TCM symptom score was modified and formulated based on the relevant contents of the "Clinical Disease Diagnosis Criteria for Cure and Improvement" and the "Guidelines for Clinical Research of New Chinese Medicines (Trial)", and the nimodipine method was used for evaluation. The efficacy index (n) = [(pre-treatment score - post-treatment score) / pre-treatment score] × 100%. Cured: n ≥ 95%; markedly effective: 70% ≤ n < 95%; improved: 30% ≤ n < 70%; ineffective: n < 30%.

[0040] 2.3.3 Safety evaluation criteria Grade 1: safe, no adverse reactions. Grade 2: relatively safe, no impact on continued administration, and no special treatment required. Grade 3: safety issues exist, moderate adverse reactions, administration can continue after treatment. Grade 4: severe adverse reactions occur and the trial is terminated.

[0041] 2.3.4 Criteria for judging the severity of adverse events Mild: Tolerable, does not affect treatment and recovery, no special treatment is required. Moderate: Unbearable, immediate discontinuation of medication or special treatment is required, and has an impact on recovery. Severe: Life-threatening, immediate discontinuation of medication or emergency treatment is required.

[0042] 2.4 Medical ethics control When patients are included in clinical research, researchers will inform patients or their families of the following matters in detail, including the patient's Chinese and Western medicine diagnosis, Chinese medicine syndrome differentiation, further treatment plan, expected treatment goals, possible adverse reactions, etc. The patient's address and telephone number will be recorded in detail for clinical follow-up treatment. When the patient's symptoms worsen or discomfort occurs after treatment, the researcher will be contacted by phone in a timely manner to stop treatment, treat the symptoms, and withdraw from the study. The whole process is based on the principle of voluntary participation and voluntary withdrawal.

[0043] 2.5 Statistical methods All data were statistically analyzed using SPSS 26.0 software. Two-sided tests were generally used for statistical tests, and differences were considered statistically significant when P < 0.05. 2For the test, the frequency, percentage or composition ratio is used to describe the data; for the rank data, the composition ratio or rate is used to describe the data; for the measurement data, the normality analysis is first performed by the KS test. The measurement data that conform to the normal distribution or are approximately conforming to the normal distribution are expressed as the mean ± standard deviation (X(—) ± S), and the measurement data that do not conform to the normal distribution are expressed as the median (quartile) or M (Q1, Q3). The data that conform to the normality and homogeneity of variance are used for the t test, otherwise the rank sum test is used.

[0044] 3. Results 3.1 Comparison of the efficacy of dynamic electrocardiography between the two groups There was no significant difference in the dynamic electrocardiogram between the two groups of patients before treatment. After treatment, both groups improved compared with before treatment. However, compared with the two groups after treatment, the improvement in the treatment group was significantly better than that in the control group (P < 0.05), as shown in Table 1.

[0045] Table 1 Comparison of the efficacy of dynamic electrocardiogram between the two groups

[0046] 3.2 Comparison of TCM symptom scores before and after treatment There was no significant difference in the TCM symptom scores of the two groups of patients before treatment. After treatment, both groups improved compared with before treatment. However, compared with the two groups after treatment, the improvement in the treatment group was significantly better than that in the control group (P < 0.05), as shown in Table 2.

[0047] Table 2 Comparison of TCM symptom scores between the two groups (X(—)±S)

[0048] Note: * The comparison between the two groups after treatment was P < 0.05.

[0049] 3.3 Adverse reactions The liver and kidney functions of patients in each group were normal before and after treatment, and no adverse reactions occurred in each group.

[0050] 4. Discussion The clinical study results show that the improvement of symptoms such as palpitation and shortness of breath, fever in the five parts of the body, hot flashes and night sweats, insomnia and dreaminess, anxiety and restlessness in the Chinese medicine treatment group is significantly better than that in the control group (oral metoprolol), with statistical significance (P < 0.05). The improvement in TCM syndrome score is better than that in the control group, with statistical significance (P < 0.05). The Chinese medicine preparation for treating tachycardia of the present invention has significant efficacy, good safety, low price and simple medicine, and has high clinical promotion value.

[0051] 5. Conclusion The clinical application effect of the Yangyin Anshen Dingji prescription of the present invention is obviously better than that of the commonly used metoprolol tartrate in clinical practice, and has good safety, thus providing a guarantee for its clinical promotion.

[0052] Example 2 Preparation of Chinese medicine preparation for treating tachycardia The formula is as follows: 10 g of cinnamon twig, 20 g of white atractylodes, 15 g of codonopsis, 25 g of cooked rehmannia, 25 g of raw dragon bone, 35 g of raw oyster, 10 g of sophora flavescens, 20 g of schisandra chinensis, 15 g of nardus, 20 g of ophiopogon japonicus, and 10 g of turtle shell. The corresponding Chinese medicine pieces are selected for each raw material.

[0053] The preparation method is as follows: (1) Mix raw dragon bone, raw oyster and turtle shell, soak in water for 30 minutes and set aside; mix cinnamon twig, white atractylodes, codonopsis, prepared rehmannia, sophora flavescens, schisandra chinensis, nard and ophiopogon japonicus, soak in water for 30 minutes and set aside; (2) Boil raw dragon bones, raw oysters and turtle shells for 20 minutes; (3) Add cinnamon twig, white atractylodes, codonopsis pilosula, rehmannia root, sophora flavescens, schisandra chinensis, nardostachys grandiflora and ophiopogon japonicus, boil for 50 minutes, and pour out the decoction. This is the first decoction. Add water to the residue and boil for another 50 minutes. Pour out the decoction. This is the second decoction. Mix the two decoctions together.

[0054] Example 3 Preparation of Chinese medicine preparation for treating tachycardia The formula is as follows: 20 g of cinnamon twig, 10 g of atractylodes macrocephala, 25 g of codonopsis pilosula, 15 g of cooked rehmannia root, 35 g of raw dragon bone, 25 g of raw oyster, 20 g of sophora flavescens, 10 g of schisandra chinensis, 25 g of nardus galangus, 10 g of ophiopogon japonicus, and 20 g of turtle shell. The corresponding Chinese medicine pieces are selected for each raw material.

[0055] The preparation method is as follows: (1) Mix raw dragon bone, raw oyster and turtle shell, soak in water for 30 minutes and set aside; mix cinnamon twig, white atractylodes, codonopsis, prepared rehmannia, sophora flavescens, schisandra chinensis, nard and ophiopogon japonicus, soak in water for 30 minutes and set aside; (2) Boil raw dragon bones, raw oysters and turtle shells for 30 minutes; (3) Add cinnamon twig, white atractylodes, codonopsis pilosula, rehmannia root, sophora flavescens, schisandra chinensis, nardostachys grandiflora and ophiopogon japonicus, boil for 30 minutes, and pour out the decoction. This is the first decoction. Add water to the residue and boil for another 30 minutes. Pour out the decoction. This is the second decoction. Mix the two decoctions together.

[0056] Example 4 Preparation of Chinese medicine preparation for treating tachycardia The prescription is: cinnamon twig 13 g, atractylodes 17 g, codonopsis pilosula 18 g, rehmannia glutinosa 22 g, raw dragon bone 28 g, raw oyster 32 g, sophora flavescens 13 g, schisandra chinensis 17 g, nard 18 g, ophiopogon japonicus 17 g, and turtle shell 13 g.

[0057] The preparation method is as follows: (1) Mix raw dragon bone, raw oyster and turtle shell, soak in water for 20 minutes and set aside; mix cinnamon twig, white atractylodes, codonopsis, prepared rehmannia, sophora flavescens, schisandra chinensis, nard and ophiopogon japonicus, soak in water for 20 minutes and set aside; (2) Boil raw dragon bones, raw oysters and turtle shells for 25 minutes; (3) Add cinnamon twig, white atractylodes, codonopsis pilosula, rehmannia root, sophora flavescens, schisandra chinensis, nardostachys grandiflora and ophiopogon japonicus, boil for 40 minutes, and pour out the decoction. This is the first decoction. Add water to the residue and boil for another 40 minutes. Pour out the decoction. This is the second decoction. Mix the two decoctions together.

[0058] Example 5 Preparation of Chinese medicine preparation for treating tachycardia The prescription is: cinnamon twig 18 g, atractylodes 13 g, codonopsis pilosula 22 g, rehmannia glutinosa 18 g, raw dragon bone 32 g, raw oyster 28 g, sophora flavescens 18 g, schisandra chinensis 12 g, nardus galangus 22 g, ophiopogon japonicus 12 g, and turtle shell 18 g.

[0059] The preparation method is as follows: (1) Mix raw dragon bone, raw oyster and turtle shell, soak in water for 40 minutes and set aside; mix cinnamon twig, white atractylodes, codonopsis, prepared rehmannia, sophora flavescens, schisandra chinensis, nard and ophiopogon japonicus, soak in water for 40 minutes and set aside; (2) Boil raw dragon bones, raw oysters and turtle shells for 25 minutes; (3) Add cinnamon twig, white atractylodes, codonopsis pilosula, rehmannia root, sophora flavescens, schisandra chinensis, nardostachys grandiflora and ophiopogon japonicus, boil for 40 minutes, and pour out the decoction. This is the first decoction. Add water to the residue and boil for another 40 minutes. Pour out the decoction. This is the second decoction. Mix the two decoctions together.

[0060] The above examples are provided to those skilled in the art to fully disclose and describe how to make and use the claimed embodiments, and are not intended to limit the scope of the disclosure herein. Modifications that are obvious to those skilled in the art will fall within the scope of the appended claims.

Claims

1. A Chinese medicine preparation for treating tachycardia, It is characterized in that It is made from the following raw materials: 10-20g of cinnamon twig, 10-20g of atractylodes macrocephala, 15-25g of codonopsis pilosula, 15-25g of rehmannia glutinosa, 25-35g of raw dragon bone, 25-35g of raw oyster, 10-20g of sophora flavescens, 10-20g of schisandra chinensis, 15-25g of nardus galangus, 10-20g of ophiopogon japonicus, and 10-20g of turtle shell.

2. The Chinese medicine preparation for treating tachycardia according to claim 1, It is characterized in that It is made of the following raw materials: 15 g of cinnamon twig, 15 g of atractylodes macrocephala, 20 g of codonopsis pilosula, 20 g of rehmannia glutinosa, 30 g of raw dragon bone, 30 g of raw oyster, 15 g of sophora flavescens, 15 g of schisandra chinensis, 20 g of nardus galangus, 15 g of ophiopogon japonicus, and 15 g of turtle shell.

3. The Chinese medicine preparation for treating tachycardia according to claim 1, It is characterized in that It is made from the following raw materials: 10 g of cinnamon twig, 20 g of white atractylodes, 15 g of codonopsis pilosula, 25 g of cooked rehmannia, 25 g of raw dragon bone, 35 g of raw oyster, 10 g of sophora flavescens, 20 g of schisandra chinensis, 15 g of nardus galangus, 20 g of ophiopogon japonicus, and 10 g of turtle shell.

4. The Chinese medicine preparation for treating tachycardia according to claim 1, It is characterized in that It is made of the following raw materials: 20 g of cinnamon twig, 10 g of atractylodes macrocephala, 25 g of codonopsis pilosula, 15 g of cooked rehmannia, 35 g of raw dragon bone, 25 g of raw oyster, 20 g of sophora flavescens, 10 g of schisandra chinensis, 25 g of nardus galangus, 10 g of ophiopogon japonicus, and 20 g of turtle shell.

5. The Chinese medicine preparation for treating tachycardia according to claim 1, It is characterized in that It is made from the following raw materials: cinnamon twig 13 g, atractylodes 17 g, codonopsis pilosula 18 g, rehmannia glutinosa 22 g, raw dragon bone 28 g, raw oyster 32 g, sophora flavescens 13 g, schisandra chinensis 17 g, nard 18 g, ophiopogon japonicus 17 g, and turtle shell 13 g.

6. The Chinese medicine preparation for treating tachycardia according to claim 1, It is characterized in that It is made of the following raw materials: cinnamon twig 18 g, atractylodes 13 g, codonopsis pilosula 22 g, cooked rehmannia glutinosa 18 g, raw dragon bone 32 g, raw oyster 28 g, sophora flavescens 18 g, schisandra chinensis 12 g, nardus galangus 22 g, ophiopogon japonicus 12 g, and turtle shell 18 g.

7. A method for preparing the Chinese medicine preparation for treating tachycardia according to any one of claims 1 to 6, It is characterized in that The following steps are involved: (1) Mix raw dragon bones, raw oysters and turtle shells, soak them in water for 20 to 40 minutes and set aside; mix cinnamon twigs, white atractylodes, codonopsis, rehmannia, sophora flavescens, schisandra chinensis, nard and ophiopogon japonicus, soak them in water for 20 to 40 minutes and set aside; (2) Boil raw dragon bones, raw oysters and turtle shells for 20 to 30 minutes; (3) Add cinnamon twig, white atractylodes, codonopsis pilosula, rehmannia root, sophora flavescens, schisandra chinensis, nardostachys grandiflora and ophiopogon japonicus, and boil for 30 to 50 minutes. Pour out the decoction. This is the first decoction. Add water to the residue and boil for another 30 to 50 minutes. Pour out the decoction. This is the second decoction. Mix the two decoctions together.

8. The preparation method according to claim 7, Features: In the step (1), the soaking time is 30 minutes.

9. The preparation method according to claim 7, Features: In the step (2), the decocting time is 25 minutes.

10. The preparation method according to claim 7, Features: In the step (3), the boiling time is 40 minutes.

Citation Information

Patent Citations

  • Chinese medicinal composition for treatment of cardiovascular diseases, preparation method and application thereof

    CN108721494A